80
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Long Intergenic Non-Protein Coding RNA 01089 Weakens Tumor Proliferation, Migration, and Invasion by Sponging miR-3187-3p in Non-Small Cell Lung Cancer

, ORCID Icon, , &
Pages 12151-12162 | Published online: 25 Nov 2020

References

  • Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85:1.30741502
  • Sun KX, Zheng RS, Zeng HM, et al. [The incidence and mortality of lung cancer in China, 2014]. Zhonghua Zhong Liu Za Zhi. 2018;40(11):805–811. Chinese.30481929
  • Zheng RS, Sun KX, Zhang SW, et al. [Report of cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi. 2019;41(1):19–28. Chinese.30678413
  • Guo H, Chang Z, Wu J, Li W. Air pollution and lung cancer incidence in China: who are faced with a greater effect? Environ Int. 2019;132:105077. doi:10.1016/j.envint.2019.10507731415963
  • Parascandola M, Xiao L. Tobacco and the lung cancer epidemic in China. Transl Lung Cancer Res. 2019;8(Suppl 1):S21–s30. doi:10.21037/tlcr.2019.03.1231211103
  • Xing DF, Xu CD, Liao XY, et al. Spatial association between outdoor air pollution and lung cancer incidence in China. BMC Public Health. 2019;19(1):1377.31655581
  • Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640. doi:10.1016/j.mayocp.2019.01.01331378236
  • Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.28604750
  • Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109. doi:10.1016/j.bbagrm.2014.08.01225159663
  • Li J, Meng H, Bai Y, Wang K. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23(5):205–217. doi:10.3727/096504016X1454966733400727098144
  • Jiang MC, Ni JJ, Cui WY, Wang BY, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9(7):1354–1366.31392074
  • Ghafouri-Fard S, Shoorei H, Branicki W, Taheri M. Non-coding RNA profile in lung cancer. Exp Mol Pathol. 2020;114:104411. doi:10.1016/j.yexmp.2020.10441132112788
  • Lu T, Wang Y, Chen D, Liu J, Jiao W. Potential clinical application of lncRNAs in non-small cell lung cancer. Onco Targets Ther. 2018;11:8045–8052. doi:10.2147/OTT.S17843130519046
  • Sas-Chen A, Aure MR, Leibovich L, et al. LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Mol Med. 2016;8(9):1052–1064. doi:10.15252/emmm.20160619827485121
  • Zeng XY, Xie H, Yuan J, et al. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther. 2019;20(7):956–966. doi:10.1080/15384047.2018.156456731062668
  • Yuan H, Qin Y, Zeng B, et al. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/beta-catenin signaling pathway in breast cancer. Onco Targets Ther. 2019;12:4883–4895. doi:10.2147/OTT.S20883031417284
  • Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–w560. doi:10.1093/nar/gkz43031114875
  • Wong NW, Chen Y, Chen S, Wang X. OncomiR: an online resource for exploring pan-cancer microRNA dysregulation. Bioinformatics. 2018;34(4):713–715. doi:10.1093/bioinformatics/btx62729028907
  • Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Databaseissue):D92–97. doi:10.1093/nar/gkt124824297251
  • Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 2018;46(D1):D239–d245. doi:10.1093/nar/gkx114129156006
  • Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4.
  • Li C, Lv Y, Shao C, et al. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis. J Cell Physiol. 2019;234(11):20721–20727. doi:10.1002/jcp.2867831032916
  • Pan J, Bian Y, Cao Z, et al. Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: a meta-analysis. Thorac Cancer. 2020;11(2):329–335. doi:10.1111/1759-7714.1326531846184
  • Moises J, Navarro A, Castellano JJ, et al. Long Non-Coding RNA NANCI/NKX2-1 duplex impacts prognosis in Stage I non-small-cell lung cancer. Arch Bronconeumol. 2020.
  • Ma HP, Wang LX, Li W, Guo HH, Wu Y, Li XY. Upregulation of LINC00504 is associated with aggressive progression and poor prognosis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2020;24(2):699–703.32016971
  • Chen Z, Chen X, Lei T, et al. Integrative analysis of NSCLC Identifies LINC01234 as an oncogenic lncRNA that interacts with HNRNPA2B1 and regulates miR-106b biogenesis. Mol Ther. 2020;28(6):1479–1493. doi:10.1016/j.ymthe.2020.03.01032246902
  • Pan J, Tang Y, Liu S, et al. LIMD1-AS1 suppressed non-small cell lung cancer progression through stabilizing LIMD1 mRNA via hnRNP U. Cancer Med. 2020;9(11):3829–3839. doi:10.1002/cam4.289832239804
  • Sun P, Sun L, Cui J, Liu L, He Q. Long noncoding RNA HAS2-AS1 accelerates non-small cell lung cancer chemotherapy resistance by targeting LSD1/EphB3 pathway. Am J Transl Res. 2020;12(3):950–958.32269726
  • Xu X, Zhou X, Chen Z, Gao C, Zhao L, Cui Y. Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin. Aging (Albany NY). 2020;12(6):2726–4711. doi:10.18632/aging.102673
  • Zhou Q, Huang SX, Zhang F, et al. MicroRNAs: a novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Cell Prolif. 2017;50:6. doi:10.1111/cpr.12394
  • Switlik WZ, Szemraj J. Circulating miRNAs as non-invasive biomarkers for non-small cell lung cancer diagnosis, prognosis and prediction of treatment response. Postepy Hig Med Dosw (Online). 2017;71:649–662. doi:10.5604/01.3001.0010.384528791959
  • Wang X, Zhang G, Cheng Z, et al. Knockdown of LncRNA-XIST suppresses proliferation and TGF-beta1-Induced EMT in NSCLC through the Notch-1 pathway by regulation of miR-137. Genet Test Mol Biomarkers. 2018;22(6):333–342. doi:10.1089/gtmb.2018.002629812958
  • Li C, Wan L, Liu Z, et al. Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer. Cancer Lett. 2018;418:185–195. doi:10.1016/j.canlet.2018.01.03629339211
  • Agrawal M, Rastogi M, Dogra S, Pandey N, Basu A, Singh SK. Chandipura virus changes cellular miRNome in human microglial cells. J Med Virol. 2019. doi:10.1002/jmv.25491
  • Vignard V, Labbe M, Marec N, et al. MicroRNAs in tumor exosomes drive immune escape in melanoma. Cancer Immunol Res. 2020;8(2):255–267. doi:10.1158/2326-6066.CIR-19-052231857348
  • Yang G, Zhang T, Ye J, et al. Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1, suppressing colorectal cancer proliferation. Cancer Manag Res. 2019;11:6499–6509. doi:10.2147/CMAR.S20313731372051
  • Davis TA, Loos B, Engelbrecht AM. AHNAK: the giant jack of all trades. Cell Signal. 2014;26(12):2683–2693. doi:10.1016/j.cellsig.2014.08.01725172424
  • Park JW, Kim IY, Choi JW, et al. AHNAK loss in mice promotes Type II pneumocyte hyperplasia and lung tumor development. Mol Cancer Res. 2018;16(8):1287–1298. doi:10.1158/1541-7786.MCR-17-072629724814
  • Gu J, Mao W, Ren W, et al. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. Cancer Lett. 2019;443:125–134. doi:10.1016/j.canlet.2018.11.02930503554